000 01651 a2200493 4500
005 20250513032255.0
264 0 _c19951103
008 199511s 0 0 eng d
022 _a0270-9139
024 7 _a10.1016/0270-9139(95)90626-6
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRolachon, A
245 0 0 _aCiprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial.
_h[electronic resource]
260 _bHepatology (Baltimore, Md.)
_cOct 1995
300 _a1171-4 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAnti-Infective Agents
_xtherapeutic use
650 0 4 _aAntibiotic Prophylaxis
650 0 4 _aAscites
_xmetabolism
650 0 4 _aBacterial Infections
_xprevention & control
650 0 4 _aCiprofloxacin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLiver Cirrhosis
_xmicrobiology
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPeritonitis
_xmicrobiology
650 0 4 _aPlacebos
650 0 4 _aProspective Studies
650 0 4 _aProteins
_xmetabolism
700 1 _aCordier, L
700 1 _aBacq, Y
700 1 _aNousbaum, J B
700 1 _aFranza, A
700 1 _aParis, J C
700 1 _aFratte, S
700 1 _aBohn, B
700 1 _aKitmacher, P
700 1 _aStahl, J P
773 0 _tHepatology (Baltimore, Md.)
_gvol. 22
_gno. 4 Pt 1
_gp. 1171-4
856 4 0 _uhttps://doi.org/10.1016/0270-9139(95)90626-6
_zAvailable from publisher's website
999 _c7557324
_d7557324